Board approves Rs 60 Crore investment in subsidiary VASPL, director reappointments
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Laboratories board approved additional investment up to Rs 60 Crore in wholly owned subsidiary VASPL via 1 percent Optionally Convertible Redeemable Preference Shares to fund working capital and general purposes. Also approved re-appointment of Managing Director Santosh Vora for 5 years from Feb 2027, second term for Independent Director Sonal Vira, continuation of Shantilal Vora past age 75, shifting of registered office to Tarapur Boisar in Palghar, and opening of new corporate office at Vikhroli Mumbai.
Rs 60 Crore infusion into subsidiary supports growth; VASPL turnover rose sharply from Rs 2 Lakh in FY25 to Rs 41.6 Crore in FY26.